Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries
Publication year
2022Source
The Lancet Psychiatry, 9, 2, (2022), pp. 113-124ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Cognitive Neuroscience
Journal title
The Lancet Psychiatry
Volume
vol. 9
Issue
iss. 2
Page start
p. 113
Page end
p. 124
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 7: Neurodevelopmental disorders DCMN: Donders Center for Medical NeuroscienceThis item appears in the following Collection(s)
- Academic publications [229196]
- Faculty of Medical Sciences [87796]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.